Panama Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama
Condition:   Poliomyelitis Interventions:   Biological: Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3);   Biological: Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3) Sponsors:   PATH;   Bill and Melinda Gates Foundation;   PT Bio Farma;   Centers for Disease Control and Prevention;   Technical Resources International, Inc. (TRI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2022 Category: Research Source Type: clinical trials